How Lain was paid
$946,495 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Jim B. LainInterim President and Chief Executive Officer | $425,000 | — | $121,500 | $359,812 | $40,183 | $946,495 |
| Kersten D. ZupferExecutive Vice President and Chief Financial Officer | $457,000 | $71,400 | $121,500 | $359,812 | — | $1,010,204 |
| Matthew DoctorFormer President and Chief Executive Officer | $600,000 | — | $371,250 | $570,000 | $45,555 | $1,586,805 |
What changed and why
- $946K$946,495 was Jim Lain’s fiscal 2025 total compensation as interim CEO.
- June 30, 2025 marked Matthew Doctor’s departure as CEO; Jim Lain became interim CEO July 1.
- $122K$121,500 in RSUs was granted to each named executive officer for fiscal 2025.
- $360K$359,812 in non-equity incentives was reported for Lain and Zupfer.
- $570K$570,000 in non-equity incentives was reported for Doctor, who forfeited his Cash LTIP award.
- 99%99% of votes cast supported the executive compensation program at the 2024 annual meeting.
Other Regis proxy statements
- 2026 proxy statement
Susan Lintonsmith paid $762,427.
Filed Sep 17, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.